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Abstract
Our objective was to assess junior doctors’ perceptions of their antibiotic prescribing practice and of bacterial resistance. We surveyed
190 postgraduate doctors still in training at two university teaching hospitals, in Nice (France) and Dundee (Scotland, UK), and 139 of
them (73%) responded to the survey. The main results presented in this abstract are combined for Nice and Dundee, because there
was no statistical difference for these points between the two hospitals. Antibiotic resistance was perceived as a national problem by
95% of the junior doctors, but only 63% rated the problem as important in their own daily practice. Their perceptions of the causes of
antibiotic resistance were sometimes at variance with available medical evidence, with excessive duration of antibiotic treatment and
poor hand hygiene practices rarely being perceived as important drivers for resistance. Only 31% and 26% of the doctors knew the cor-
rect prevalences of antibiotic misuse and of methicillin-resistant Staphylococcus aureus in hospitals, respectively. They preferred educa-
tional interventions, such as speciﬁc teaching sessions, availability of guidelines or readily accessible advice from an infectious diseases
specialist, to improve antibiotic prescribing, rather than restricted prescription of antibiotics. These data provide helpful information for
the design of strategies to optimize adherence to good antimicrobial stewardship.
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Introduction
Antibiotic resistance is a growing problem worldwide, with
an often negative impact on patient outcomes [1]. Between
20% and 50% of antibiotic use is either unnecessary or
inappropriate [2,3], and decreasing it is a necessary ﬁrst
step to curb antibiotic resistance. This knowledge has led
to the development of national recommendations to
improve antibiotic stewardship in countries such as the
USA, France and Scotland [2,4–6]. The evidence suggests
that a multifaceted approach is favoured, aimed at improv-
ing the organization of the healthcare system and changing
physicians’ prescribing behaviour [2,7]. Guidelines or similar
well-intentioned interventions are often not enough to
change behaviour in clinical practice [8]. Few studies on
physicians’ attitudes towards and knowledge and percep-
tions of antibiotic resistance and prescribing in the inpatient
setting have been published: two in the USA and one in
Brazil [9–12]. These results are not necessarily applicable in
other settings.
We surveyed junior training-grade doctors from all clinical
specialties in two public teaching hospitals (Nice, France, and
Dundee, Scotland, UK) to assess their knowledge, attitudes
and perceptions concerning antibiotic resistance and pre-
scribing. Our goal was to gain some understanding of this
process in two different cultural contexts, so as to enable
the design and implementation of more effective antibiotic
stewardship interventions in these hospitals.
ª2010 The Authors
Journal Compilation ª2010 European Society of Clinical Microbiology and Infectious Diseases
ORIGINAL ARTICLE INFECTIOUS DISEASES
Participants and Methods
Setting and participants
We conducted a survey of all eligible junior doctors in
Dundee, Scotland, UK (November 2007) and Nice, France
(January 2008), using a self-administered questionnaire. The
term ‘junior doctors’ referred to doctors after qualiﬁcation
from medical school who were still in their training years. In
both countries, doctors were ﬁrst-year trainees at the same
stage in their medical training, after 5 and 6 years of under-
graduate training in Dundee and Nice, respectively. Junior
doctors were identiﬁed in both hospitals using data provided
by the University Human Resources Department. Junior doc-
tors eligible for the survey included all juniors prescribing
antibiotics in their clinical practice (specialties such as labora-
tory medicine, radiology, psychiatry and occupational health
were excluded) and currently on a clinical rotation (exclud-
ing, for example, those on maternity leave or doing research
for a degree). In Dundee, only ﬁrst-year junior doctors (after
qualiﬁcation from medical school and termed foundation
doctors) were included, whereas ﬁrst-year and second-year
junior doctors were surveyed in Nice. The level of clinical
training and overall competency was deemed equal for both
cohorts (in the opinion of C.P. and D.N.). The characteristics
of the hospitals in Nice and Dundee are described in
Table 1.
Survey instrument
The questionnaire was developed in consultation with a group
of experts on questionnaire design and infectious diseases, and
after searching the literature for comparable studies [9–11].
The questionnaire was was submitted in a pilot test to ten
junior doctors to check comprehension and clarity of the
questions. The 56-item self-administered questionnaire col-
lected information on junior doctors’ attitudes about antibiotic
prescribing, their perception of the importance of the problem
of antibiotic resistance, their knowledge of the national preva-
lence of antibiotic resistance and local prevalence of antibiotic
misuse, their beliefs about the causes of antibiotic resistance,
and their attitudes about current and potential interventions
designed to improve antibiotic stewardship. Data were also
collected about their current specialty, the frequency with
which they prescribed antibiotics, and past training in antibiotic
prescribing. The questionnaire is included in the Supporting
Information section (or is available from C.P.), in both English
and French (with identical questions).
Most questions about perceptions and attitudes used four-
point or ﬁve-point Likert-style response options, from very
unhelpful/unimportant/unconﬁdent, to very helpful/important/
conﬁdent. To assess knowledge of the prevalence of antibi-
otic resistance, junior doctors were asked to estimate the
prevalence of resistance in their country for two speciﬁc
bacterium–antibiotic combinations relevant to clinical prac-
tice: Escherichia coli resistance to trimethoprim in Scotland
TABLE 1. Nice and Dundee hospitals’ characteristics and antibiotic policy
Characteristic Nice hospital Dundee hospital
University public teaching hospital Yes Yes
Number of beds 1800 900
Prevalence rate of MRSA in 2007 27% (25.8% in France, EARSS data) 34% (34.8% in Scotland, HPS data)
Prevalence of antibiotic misuse in 2005 32–64% 23–30%
Use of antibiotics (DDD)/1000 patient-days) in 2007 376 1250 (possibly overestimated)
Local guidelines Yes, available on the Internet Yes, available on the Internet
Antibiotic committee Yes Yes
Antimicrobial management team Yes Yes
List of broad-spectrum antibiotics requiring approval
by ID specialist or microbiologist before prescription
Yes Yes
Intravenous–oral switch protocol No Yes
Availability of ID advice Face-to-face or by phone, available
at all times, on all wards
Mainly through request for clinical
consultation, emphasis on internal
medicine and general surgery/orthopaedics,
but also some advice by phone; only
during working hours
Availability of microbiologist advice By phone during the day Mainly by phone, but in some areas (e.g.
ICU and haematology) clinical consultation
is available at all times
Qualiﬁcation of microbiologists Medical graduates Medical graduates
Availability of clinical pharmacists By phone, available at all times By phone, available at all times, plus ward
rounds during the day
Computer-based prescribing system No No
Junior doctors’ access to pharmaceutical representatives Not restricted Restricted
Duration of rotation on wards 6 months 4 months
DDD, deﬁned daily dose; EARSS, European Antimicrobial Resistance Surveillance System; HPS, Health Protection Scotland; ICU, intensive-care unit; ID, infectious diseases;
MRSA, methicillin-resistant Staphylococcus aureus.
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and to ﬂuoroquinolones in France in community-acquired
infections, and Staphylococcus aureus resistance to methicillin
in hospital-acquired infections in both countries. Rates of
resistance in 2005 were obtained from national surveillance
systems: the Observatoire National de l’Epide´miologie de la
Re´sistance Bacte´rienne aux Antibiotiques (ONERBA, http://
www.onerba.org) for France, and Health Protection Scotland
for Scotland (http://www.hps.scot.nhs.uk). We also assessed
knowledge of the local prevalence of antibiotic misuse;
recent rates of misuse were obtained from local audits, pub-
lished in Nice [3,13–16] and unpublished in Dundee. On the
basis of a review of the literature [2,4–6,17], we selected
nine essential steps of an antibiotic prescribing process,
seven possible causes of antibiotic resistance and 14 possible
interventions for inclusion in the questionnaire.
Survey administration
We distributed the questionnaire in November 2007 in Dun-
dee, when the junior doctors had been working for
3 months. The doctors were asked to complete the survey at
the beginning of a compulsory training session on sepsis man-
agement and prescribing. They had no prior warning of the
survey. However, as only 75% or higher attendance at all ses-
sions was required to complete their annual continuing pro-
fessional requirements, the doctors could choose to be
absent from these sessions. In Nice, the questionnaire was
sent by E-mail and mail in January 2008, when the junior doc-
tors had been working for 3 months and more, and could be
returned by fax, E-mail or mail in the provided envelope.
Questionnaires not returned within 3 weeks triggered E-mail
and mail reminders. Questionnaires not returned within
6 weeks triggered telephone call reminders. A tracking num-
ber was used for each participant to ensure conﬁdentiality.
Statistical methods
Percentages were calculated for the categorical data. Univari-
ate analysis used the chi-square test for categorical data, or
Fisher’s exact test when needed. Results are presented for
each hospital, and also combined when comparison of data
from Dundee and Nice did not show any statistically signiﬁ-
cant difference. We analysed all data using SPSS software,
version 15 (SPSS Inc., Chicago, IL, USA) and SAS software,
version 8.2. All reported p-values were two-tailed, and a p-
value <0.05 was considered to be signiﬁcant.
Results
Of the 190 eligible junior doctors, 139 (73%) returned ques-
tionnaires, 63 of 90 (70%) in Dundee (all of the doctors who
attended the training session) and 76 of 100 (76%) in Nice;
82 junior doctors were from medical specialties, and 39
were from surgical specialties (specialty was missing in 18
questionnaires). Thirty per cent of junior doctors did not
attend their training session in Dundee, and 24% did not
return the questionnaire in Nice. We can provide no reason
for why they did not attend or return the questionnaires.
Antibiotic resistance
Importance of the problem of antibiotic resistance. Most respon-
dents (95%) perceived antibiotic resistance as a national
problem, but only 63% believed that it was a problem in
their clinical practice (Table 2). The perception that resis-
tance was a problem in clinical practice was not inﬂuenced
by past training experience (77% vs. 72%, v2 = 0.35, p 0.55,
n = 111).
Perceptions of causes of antibiotic resistance. Three factors
were perceived as being important causes of antibiotic resis-
tance: prescription of too many antibiotics, prescription of
too many broad-spectrum antibiotics, and prescription of
subtherapeutic doses of an antibiotic (Fig. 1). The factors
most frequently identiﬁed as unimportant or neutral were:
paying too much attention to pharmaceutical representa-
tives/advertising, excessive use of antibiotics in livestock, and
poor hand hygiene. Dundee junior doctors were less likely
to perceive drug advertising or subtherapeutic doses of an
antibiotic as potential causes of resistance (Fig. 1).
Knowledge
Knowledge of the prevalence of antibiotic resistance. Any preva-
lence of E. coli resistance in community-acquired infections
between 5% and 20% for trimethoprim in Scotland and <5%
for ﬂuoroquinolones in France was considered to be a cor-
rect answer. Dundee junior doctors gave correct prevalence
rates in 56% of the questions, vs. 16% for Nice doctors
(p <0.001) (Table 2). Knowledge of this prevalence rate was
not inﬂuenced by past training experience (35% of correct
answers among junior doctors who received some training
vs. 32% of correct answers among those who were not
trained; v2 = 0.12, p 0.73, n = 136).
Any prevalence of S. aureus resistance to methicillin in
hospital-acquired infections between 21% and 50% was con-
sidered to be a correct answer in both Scotland and France.
Results in Nice and Dundee were not statistically different,
with 26% of junior doctors giving the correct answer, and
48% of respondents underestimating the real prevalence
(Table 2). Knowledge of this prevalence rate was not inﬂu-
enced by past training experience (26% of correct answers
among junior doctors who received some training vs. 27% of
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correct answers among those who were not trained;
v2 = 0.004, p 0.95, n = 136).
Knowledge of antibiotic misuse prevalence. Any prevalence of
antibiotic misuse between 21% and 50% in both hospitals
was considered to be a correct answer (see Participants and
Methods). Results in Nice and Dundee were not statistically
different, and the percentage of junior doctors giving the
correct answer for the prevalence of antibiotic misuse
was 31%, with 51% of respondents underestimating the real
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FIG. 1. Perceptions of causes of antibiotic resistance. Data from Nice and Dundee were compared using Fisher’s exact test.
TABLE 2. Antibiotic resistance and prescribing: perceptions, knowledge and practice in Nice and Dundee
Question
Nice, n (%)
N = 76
Dundee, n (%)
N = 63 p-Valuea
Combined answers, n (% (95% CI))
N = 139
Perception of the problem of antibiotic resistanceb
National problem 71/75 (95) 58/61 (95) 1 129/136 (95 (91–99))
Problem in the hospital 45/75 (60) 48/62 (77) <0.03 –
Problem in clinical practice 51/75 (68) 33/59 (56) 0.15 84/134 (63 (54–71))
Knowledge of the correct rate of prevalenceb
Escherichia coli resistance 12/75 (16) 35/62 (56) <0.001 –
Staphylococcus aureus resistance 22/75 (29) 14/62 (23) 0.37 36/137 (26 (19–34))
Antibiotic misuse 28/75 (37) 15/62 (24) 0.10 43/137 (31 (24–39))
Number of antibiotics prescribed in the last week
£2 39/74 (53) 27/62 (44) 0.42 66/136 (48 (40–57))
3–5 25/74 (34) 22/62 (35) 0.42 47/136 (35 (27–43))
>5 10/74 (14) 13/62 (21) 0.42 23/136 (17 (11–23))
Training in antibiotic prescribing in the last 12 months 45/76 (59) 51/61 (84) 0.002 –
Lectures 31/45 (69) 39/51 (76) 0.31 70/96 (73 (64–82))
Workshops 18/45 (40) 13/51 (25) 0.15 31/96 (32 (23–42))
Informal education in the clinical workplace 7/45 (16) 19/51 (37) 0.01 –
Web-based learning 4/45 (9) 26/51 (51) <0.001 –
Self-directed learning 16/45 (36) 24/51 (47) 0.22 40/96 (42 (32–52))
Factors inﬂuencing antibiotic prescribing
Previous experience 67/74 (91) 54/61 (89) 0.70 121/135 (90 (85–95))
Guidelines 67/74 (91) 59/61 (97) 0.18 126/135 (93 (89–98))
ID advice 50/74 (68) 38/61 (62) 0.52 88/135 (65 (57–73))
Senior colleague advice 44/74 (59) 60/61 (98) <0.001 –
Microbiologist advice 17/74 (23) 57/61 (93) <0.001 –
Pharmacist advice 2/74 (3) 48/61 (79) <0.001 –
ID, infectious diseases.
aData were compared between Nice and Dundee using the chi-square test or Fisher’s exact test when needed.
b‘Unsure’ answers were grouped with ‘no’ answers for the analysis.
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prevalence (Table 2). Knowledge of this prevalence rate was
not inﬂuenced by past training experience (31% of correct
answers among junior doctors who received some training
vs. 34% of correct answers among those who were not
trained; v2 = 0.17, p 0.68, n = 136).
Antibiotic prescribing
All but two of 139 (1.4%) junior doctors had prescribed an
antibiotic within the last 6 months. Forty-eight per cent of
junior doctors had prescribed two or fewer antibiotics in
the last week, 35% three to ﬁve antibiotics, and 17% more
than ﬁve antibiotics, without any difference between the two
hospitals (Table 2).
Ninety-six of 137 (70%) had received some training in
antibiotic prescribing in the past 12 months, with doctors in
Dundee having had more training than doctors in Nice (84%
vs. 59%; v2 = 9.6, p 0.002, n = 137) (Table 2).
Attitudes during the antibiotic prescribing process. Junior doc-
tors appear to feel relatively conﬁdent when prescribing
an antibiotic, with Dundee junior doctors being more
conﬁdent than Nice doctors for six of nine scenarios
(Fig. 2).
Perceptions of the factors inﬂuencing the antibiotic prescribing
process. Dundee junior doctors were more likely to seek
advice from a senior colleague, a microbiologist or a pharma-
cist for their prescribing decisions than doctors in Nice
(Table 2).
Perceptions of the helpfulness of potential interventions to improve
antibiotic prescribing. The three measures rated as the most
helpful interventions for improving prescribing were availa-
bility of guidelines, educational sessions, and availability of
microbiological and infectious diseases advice (Fig. 3). Dun-
dee junior doctors placed greater value on advice from a
microbiologist, pharmacist and infection control team,
although both groups appeared to value the availability of an
antimicrobial management team. The inﬂuence of pharmaceu-
tical representatives and restriction of all antibiotics were
regarded as unhelpful (Fig. 3).
Discussion
Although 95% of our sample viewed antibiotic resistance
as a national problem, only 63% believed that resistance
65
97
71
89
58
89
40
79
58
48
33
75
44
58
26
36
20
51
35
3
29
11
42
11
60
21
42
52
67
25
56
42
74
64
80
49
0% 20% 40% 60% 80% 100%
Nice (%)
Dundee (%)
Making an accurate diagnosis of infecon/sepsis (N = 135, p < 0.001)
Nice (%)
Dundee (%)
Interpreng microbiological results (N = 130, p 0.01) 
Nice (%)
Dundee (%)
Choosing between IV and PO administraon (N = 136, p < 0.001) 
Nice (%)
Dundee (%)
Choosing the correct dose and interval of administraon (N = 136, p < 0.001) 
Nice (%)
Dundee (%)
Not prescribing an anbioc if no severity and uncertain diagnosis (N = 128, p 0.26)
Nice (%)
Dundee (%)
Choosing the correct anbioc (N = 134, p < 0.001) 
Nice (%)
Dundee (%)
Planning to streamline/stop the anbioc treatment (N = 130, p 0.11)
Nice (%)
Dundee (%)
Planning the duraon of the anbioc treatment (N = 130, p 0.24)
Nice (%)
Dundee (%)
Using a combinaon therapy if appropriate (N = 132, p 0.001)
Condent or very condent Uncondent or very uncondent
FIG. 2. Conﬁdence level (percentage of doctors) for nine scenarios during an antibiotic prescribing process. Data were collapsed into two cate-
gories and compared between Nice and Dundee using Fisher’s exact test. IV, intravenous; PO, oral.
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was a problem in their practice. These ﬁndings are consis-
tent with those of a study of internists [9]. Other, more
recent, studies have found a higher level of awareness of
the problem of antibiotic resistance [10,11]. Training did
not appear to be associated with a better awareness of
antibiotic resistance in our study, although one survey of
internal medicine junior and senior doctors found that
previous personal experience with resistance was the best
predictor of a better recognition of the problem of antibi-
otic resistance in practice [9].
Attitudes regarding the different components of the antibi-
otic prescribing process varied according to the scenario
studied in our questionnaire. Junior doctors were most con-
ﬁdent when making a diagnosis, and less conﬁdent in stream-
lining or stopping antibiotic therapy, planning the correct
duration of treatment, or using a combination therapy appro-
priately. The high level of conﬁdence reported in our study
in making the correct diagnosis is not supported by evidence,
as misdiagnosis has been shown to be the leading cause of
unnecessary antibiotic prescriptions [3].
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FIG. 3. Junior doctors’ ratings of the helpfulness of potential interventions to improve antibiotic prescribing. Data from Nice and Dundee were
compared using Fisher’s exact test. ID, infectious diseases.
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At both sites, junior doctors favoured more educative
interventions to improve antibiotic prescribing rather than
restrictive ones, as noted previously [9]. However, restric-
tion of prescription of some antibiotics was perceived as
helpful by the majority of respondents, possibly because this
measure had been in place for a long time at both hospitals.
Availability of advice from an infectious diseases specialist and
a microbiologist as well as audit and feedback strategies were
also highly valued by respondents. These ﬁndings are consis-
tent with an Australian study surveying medical staff attitudes
to an antibiotic approval and stewardship programme [18].
We observed many similarities between Nice and Dun-
dee, thereby conﬁrming the external validity of our results;
most of the differences observed can be explained by the
contextual differences detailed in Table 1. For example,
Dundee doctors had a greater tendency than those in
Nice to seek advice from a microbiologist or a pharmacist
and to perceive them as helpful, probably because these
professionals in Dundee are traditionally regarded as an
easily accessible source of advice for junior doctors work-
ing on the wards.
To our knowledge, only three surveys published in English
of antibiotic use and resistance have included junior doctors
in the inpatient setting [9–11]. Only one of them [10] speciﬁ-
cally surveyed junior doctors and studied antibiotic use.
Therefore, our two-centre study of junior doctors at similar
stages of training from all specialties in two European hospi-
tals provides a unique comparison, and is strengthened by an
adequate response rate of 73%, which is comparable with
the rate of 67–87% in other published studies [9–11].
However, our study has signiﬁcant limitations. First, as
with most surveys, there is a possibility that respondents
gave socially desirable answers. To minimize this potential
bias, we ensured complete respondent conﬁdentiality. We
also believe that certain ﬁndings of the survey support its
internal validity. For example, 30% of those surveyed stated
that they had had no training in antibiotic prescribing in the
past year, or some junior doctors rated the value of accessi-
ble advice from a pharmacist as being only moderately help-
ful in improving antibiotic prescribing, despite the perceived
evidence of what would be regarded as a more desirable
answer. Secondly, the differences in methodology in adminis-
tering the questionnaire between Nice and Dundee might
limit the comparability of the results, as the doctors in Dun-
dee completed the questionnaire at a designated session and
had no prior warning of the study. By contrast, doctors in
Nice had the opportunity to verify their answers. However,
we believe that the ability to verify answers would impact
mostly on knowledge, and not on the assessment of percep-
tions. The fact that fewer than one-third of Nice junior doc-
tors gave correct answers for prevalence rates, which are
easily checkable, suggests that it is unlikely that they
searched for answers. Finally, the small number of participat-
ing physicians could limit the validity of the results reported
for physicians at large. However, 95% CIs for the combined
answers in Table 2 were quite narrow, thereby strengthening
the conﬁdence in our results.
What have we learnt from these surveys that will help us
to improve our interventions or their implementation and
impact? Local guidelines need to give precise indications con-
cerning intravenous–oral switch criteria, antibiotic combina-
tion choice criteria, and optimal durations of antibiotic
treatments; this was not the case in one-ﬁfth of 170 hospitals
from 32 European countries [19]. Quality improvement
interventions using an audit and feedback method are likely
to be successful, as they will combine all factors valued by
our respondents: value of experience, and advice from senior
colleagues and various specialists (infectious diseases special-
ist in Nice and Dundee, with the addition of pharmacists and
microbiologists in Dundee). We plan to focus on the reas-
sessment of antibiotic prescriptions 2–4 days after the start
of therapy, as it could improve issues such as the clarity of
the diagnosis, intravenous–oral switch, and streamlining or
cessation of therapy [4,20]. An outline of our practical imple-
mentation plan is described in Table S1.
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